Department of Public Health and Community Medicine, University of Verona, Piazzale LA Scuro 10, 37134, Verona, Italy.
BMC Psychiatry. 2012 Jul 12;12:78. doi: 10.1186/1471-244X-12-78.
Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials.
We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome.
The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m(2) reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact.
When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders.
与普通人群相比,精神疾病患者的身体健康问题更多,预期寿命更短,这主要是由于过早发生心血管疾病所致。多病因模型包括更高的风险因素患病率,为这一现象提供了合理的解释。该模型不仅考虑了性别、年龄和家族史等不可改变的风险因素,还考虑了肥胖、吸烟、糖尿病、高血压和血脂异常等可通过行为改变和改善护理来改变的风险因素。因此,关注增加心血管风险的因素至关重要。肥胖与精神分裂症患者的生活方式习惯和抗精神病药物的副作用都有一定关联。本系统综述和荟萃分析旨在收集和更新有关随机临床试验中针对精神疾病患者的非药物健康促进计划的有效性的现有证据。
我们系统地回顾了 1990 年以后发表的随机对照试验,其中比较了针对精神疾病患者的减肥或预防体重增加的心理教育和/或认知行为干预与常规治疗。我们进行了荟萃分析,并将研究结果汇总为主要结局的体重指数。
荟萃分析的结果表明实验组有效。在干预阶段结束时,精神疾病患者的平均体重指数降低了 0.98kg/m2。值得注意的是,针对个体的心理教育计划,包括饮食和/或体育活动的预防研究似乎具有最大的影响。
与精神疾病患者的常规治疗相比,包含饮食和体育活动的预防和个体化生活方式干预通常可以有效减轻体重。身体筛查和监测计划受到患者的广泛认可,并可在多种环境中实施。体重指数降低 0.98 点相当于初始体重减轻 3.12%。这一百分比低于改善高血压、2 型糖尿病和血脂异常等与体重相关的并发症所需的 5%至 10%的体重减轻。然而,据报道,代谢风险因素的相关结果可能比体重变化本身具有更大的健康意义。因此,除了减轻体重外,还应将代谢参数的评估纳入精神障碍患者的身体健康促进和管理中,以监测其他独立的风险因素。